Navigation Links
Going negative: Stanford scientists explore new technologies that remove atmospheric CO2
Date:2/16/2013

sequestered than are released into the atmosphere," explained Milne, an energy assessment analyst at GCEP. "One of the most promising net-negative technologies is BECCS, or bioenergy with carbon capture and storage."

A typical BECCS system converts woody biomass, grass and other vegetation into electricity, chemical products or fuels, such as ethanol. CO2 emissions released during the process are captured and stored. The technology can be used in power plants, paper mills, ethanol processors and other manufacturing facilities.

As a carbon-negative technology, BECCS takes advantage of the innate ability of trees, grasses and other plants to absorb atmospheric CO2 for photosynthesis. In nature, the CO2 is eventually released back into the atmosphere as the plant decays. But when vegetation is processed at a BECCS facility, the CO2 emissions are captured and prevented from re-entering the environment. The result is a net-negative reduction in atmospheric CO2.

The GCEP report identified 16 BECCS projects at various stages of development around the world. The first project was launched in 2009 by the Department of Energy at a corn ethanol production facility in Decatur, Ill., operated by the Archer Daniel Midlands Company. Each day, about 1,000 metric tons of CO2 emitted during ethanol fermentation are captured and stored in a sandstone formation some 7,000 feet underground. The goal of the project is to sequester 1 million metric tons of CO2 a year the equivalent of removing 200,000 automobiles from the road.

Approximately 60 percent of global CO2 emissions come from power plants and other industries fueled by coal, natural gas and oil. Capturing and sequestering those emissions could play a significant role in curbing global warming. To make the process carbon negative, researchers have proposed a BECCS co-fired power plant that runs on a mixture of fossil fuel (such as coal) and vegetation (wood, grass or straw, for example). A p
'/>"/>

Contact: Mark Shwartz
mshwartz@stanford.edu
650-723-9296
Stanford University
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. Going trayless study shows student impact
2. Protein production: Going viral
3. 23andMes Ancestry Composition reveals peoples ancestral origins going back 500+ years
4. Temple-Penn researchers identify calcium accelerator to keep cell power supply going
5. When the going gets tough, the tough get... more relief from a placebo?
6. Going with the flow
7. Preventing the immune system from going haywire during sepsis
8. The physics of going viral
9. Penn research points to new way of preserving fertility for boys undergoing cancer treatment
10. Stanford scientist uncovers the reproductive workings of a harvester ant dynasty
11. Stanford researcher sheds new light on the mysteries of spider silk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/8/2015)... -- Trovagene, Inc. (NASDAQ: TROV ), a developer of cell-free ... Cancer Monitoring SM platform will be presented at the ... San Diego, CA on June 11-12 , ... Genomics and Cancer Therapy in Salt Lake ... "We continue to advance our clinical programs and present data ...
(Date:6/5/2015)... 5, 2015  Intrexon Corporation ("Intrexon") (NYSE: XON ... it has determined the final distribution ratio relating to ... shares of ZIOPHARM Oncology, Inc. ("ZIOPHARM") (NASDAQ: ZIOP ... the distribution date, as a pro rata dividend on ... purchase shares of Intrexon common stock ("Warrants"), outstanding on ...
(Date:6/1/2015)... June 1, 2015 According to ... Sensing Market by Technology (Touch-based & Touchless), Application (Consumer ... & by Geography - Global Forecast to 2020", published ... is expected to reach $23.55 Billion by 2020, at ... Browse 83 market data T ables ...
Breaking Biology News(10 mins):Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 2Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 4Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 2Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 3Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 4Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 2Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 3Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 4
... 2011 The risk of deadly hantavirus outbreaks in people ... images to monitor surges in vegetation that boost mouse populations, ... forecast outbreaks of other rodent-borne illnesses worldwide. "It,s a ... out and trap animals all the time," says Denise Dearing, ...
... analysis of sulfur emissions appearing in the journal ... for a decade, worldwide emissions rose again in 2000 ... economy. An accurate read on sulfur emissions will help ... day effects on the atmosphere, health and the environment. ...
... MADISON Recalculating the global use of phosphorous, a fertilizer ... the world,s stocks may soon be in short supply and ... cause of the pollution of lakes, rivers and streams. ... Environmental Research Letters , Stephen Carpenter of the University of ...
Cached Biology News:Monitoring killer mice from space 2Monitoring killer mice from space 3Monitoring killer mice from space 4Monitoring killer mice from space 5Worldwide sulfur emissions rose between 2000-2005, after decade of decline 2Worldwide sulfur emissions rose between 2000-2005, after decade of decline 3Worldwide sulfur emissions rose between 2000-2005, after decade of decline 4World phosphorous use crosses critical threshold 2World phosphorous use crosses critical threshold 3
(Date:6/30/2015)... , June 30, 2015  Juniper Pharmaceuticals, ... focused on developing therapeutics that address unmet medical ... George Elston will present at the ... Wednesday, July 8, 2015Time: , 4:45 PM EDTLocation: ... (live & archive): , www.juniperpharma.com, under  ,Investor, ...
(Date:6/30/2015)... FL (PRWEB) , ... June 30, 2015 , ... The ... 7.76% of Cryo-Cell’s currently outstanding common shares (including shares of unvested restricted stock). On ... offer, the last sale price of Cryo-Cell’s shares reported on the OTCBB was $2.29 ...
(Date:6/30/2015)... 30, 2015  The Dr. Samadi Prostate Cancer Center in ... a full suite of new genetic testing methods for men ... diagnosing prostate cancer. Dr. Samadi,s Prostate ... for assessing the risk and optimizing the diagnosis of prostate ... excited to now offer these revolutionary genetic tests to men ...
(Date:6/29/2015)... June 30, 2015   Pharnext SAS today announced ... for the treatment of Charcot-Marie-Tooth Type 1A (CMT1A), is being ... 2015 Peripheral Nerve Society (PNS) Biennial Meeting at the Quebec ... June 27 - July 2, 2015. At Poster ... July 1, 5p.m. to 7p.m. EDT: Poster ...
Breaking Biology Technology:Juniper Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 2New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 3New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 4New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 5Pharnext's PXT-3003 Featured in Multiple Presentations at 2015 Peripheral Nerve Society Biennial Meeting 2
... The long-awaited speaking faculty for the September Pharma ... the conference website reports Mark Alexay, President of ... is comprised of 100 speakers from pharmaceutical companies ... in the pipeline. The speaker list may be ...
... of Avastin Will Take Market Share Away from ... New Report from Decision ResourcesWALTHAM, Mass., March 10 ... research and advisory firms for pharmaceutical and healthcare ... in the age-related macular degeneration (AMD) market through ...
... March 10 Christine Lawless, MD, has ... an ACCME-accredited provider of continuing medical education (CME), beginning ... leading authorities in sports medicine cardiology, Dr. Lawless recently ... University Medical Center, where she was Associate Professor ...
Cached Biology Technology:Pharma ChemOutsourcing Unveils 100 Pharma & Biotech Speaker Faculty for 2009 Conference September 14-16 in Long Branch, NJ 2Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe 2Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe 3Former President of Sports Cardiology Consultants, LLC Christine Lawless, MD, MBA, ABCL, FACC, FACSM, Named Medical Director of CME Enterprise 2
Mouse monoclonal [AZ24] to Polo like kinase ( Abpromise for all tested applications)....
... Applied Science, which pioneered the blending of ... Fidelity and Expand Long Template PCR Systems, ... System the first product of a ... new blend combines Taq DNA Polymerase with ...
... RY 13 5'G AATTC3' 3'CTTAA G5' Inactivation Conditions: ... ethanol precipitation. Storage Conditions: 10mM Tris-HCl (pH 7.5), ... X-100, 0.01% BSA, 50% glycerol. Shipping and Storage: ... Definition: One unit is defined as the amount ...
... Source: Bacillus globigii 5'GCCNNNN NGGC3' 3'CGGN NNNNCCG5' ... 15 min or phenol treatment followed by ... 8.0), 200mM KCl, 0.1mM EDTA, 1.0mM DTT, ... Shipped on dry ice. Store at -20C. ...
Biology Products: